Areti A, Yerra VG, Naidu V, Kumar A (2014) Oxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy. Redox Biol 2:289–295. https://doi.org/10.1016/j.redox.2014.01.006

Article  CAS  PubMed  PubMed Central  Google Scholar 

Authier N, Gillet JP, Fialip J, Eschalier A, Coudore F (2003) An animal model of nociceptive peripheral neuropathy following repeated cisplatin injections. Exp Neurol 182(1):12–20. https://doi.org/10.1016/s0014-4886(03)00003-7

Article  CAS  PubMed  Google Scholar 

Badawi GA, Abd El Fattah MA, Zaki HF, El Sayed MI (2019) Sitagliptin and liraglutide modulate L-dopa effect and attenuate dyskinetic movements in Rotenone-Lesioned rats. Neurotox Res 35(3):635–653. https://doi.org/10.1007/s12640-019-9998-3

Article  CAS  PubMed  Google Scholar 

Briyal S, Shah S, Gulati A (2014) Neuroprotective and anti-apoptotic effects of liraglutide in the rat brain following focal cerebral ischemia. Neuroscience 281:269–281. https://doi.org/10.1016/j.neuroscience.2014.09.064

Article  CAS  PubMed  Google Scholar 

Calls A, Torres-Espin A, Navarro X, Yuste VJ, Udina E, Bruna J (2021) Cisplatin-induced peripheral neuropathy is associated with neuronal senescence-like response. Neurooncology 23(1):88–99. https://doi.org/10.1093/neuonc/noaa151

Article  CAS  Google Scholar 

Ceyhan D, Kocman AE, Yildirim E, Ozatik O, Aydin S, Kose A (2018) Comparison of the effects of Curcumin, Tramadol and surgical treatments on neuropathic pain induced by chronic constriction injury in rats. Turk Neurosurg 28(2):288–295. https://doi.org/10.5137/1019-5149.JTN.19824-17.0

Article  PubMed  Google Scholar 

Chen L, Watson C, Morsch M, Cole NJ, Chung RS, Saunders DN, Yerbury JJ, Vine KL (2017) Improving the delivery of SOD1 antisense oligonucleotides to motor neurons using calcium Phosphate-Lipid nanoparticles. Front Neurosci 11:476. https://doi.org/10.3389/fnins.2017.00476

Article  PubMed  PubMed Central  Google Scholar 

Cioroiu C, Weimer LH (2017) Update on Chemotherapy-Induced peripheral neuropathy. Curr Neurol Neurosci Rep 17(6):47. https://doi.org/10.1007/s11910-017-0757-7

Article  PubMed  Google Scholar 

Cummings BP, Stanhope KL, Graham JL, Baskin DG, Griffen SC, Nilsson C, Sams A, Knudsen LB, Raun K, Havel PJ (2010) Chronic administration of the glucagon-like peptide-1 analog, Liraglutide, delays the onset of diabetes and lowers triglycerides in UCD-T2DM rats. Diabetes 59(10):2653–2661. https://doi.org/10.2337/db09-1564

Article  CAS  PubMed  PubMed Central  Google Scholar 

Deuis JR, Dvorakova LS, Vetter I (2017) Methods Used to Evaluate Pain Behaviors in Rodents. Front in Mol Neurosci 10:284. https://doi.org/10.3389/fnmol.2017.00284

Article  Google Scholar 

Donertas B, Cengelli Unel C, Aydin S, Ulupinar E, Ozatik O, Kaygisiz B, Yildirim E, Erol K (2018) Agmatine co-treatment attenuates allodynia and structural abnormalities in cisplatin-induced neuropathy in rats. Fundam Clin Pharmacol 32(3):288–296. https://doi.org/10.1111/fcp.12351

Article  CAS  PubMed  Google Scholar 

Erdogan MA, Taskıran E, Yigittürk G, Erbaş O, Taskıran D (2020) The investigation of therapeutic potential of oxytocin and liraglutide on vincristine-induced neuropathy in rats. J Biochem Mol Toxicol. https://doi.org/10.1002/jbt.22415

Article  PubMed  Google Scholar 

Ferrier J, Marchand F, Balayssac D (2016) Assessment of mechanical allodynia in rats using the electronic von Frey test. BIO-Protoc 6:18. https://doi.org/10.21769/BioProtoc.1933

Article  Google Scholar 

Fukuda S, Nakagawa S, Tatsumi R, Morofuji Y, Takeshita T, Hayashi K, Tanaka K, Matsuo T, Niwa M (2016) Glucagon-Like Peptide-1 strengthens the barrier integrity in primary cultures of rat brain endothelial cells under basal and hyperglycemia conditions. J Mol Neurosci 59(2):211–219. https://doi.org/10.1007/s12031-015-0696

Article  CAS  PubMed  Google Scholar 

Gong N, Xiao Q, Zhu B, Zhang CY, Wang YC, Fan H, Ma AN, Wang YX (2014) Activation of spinal glucagon-like peptide-1 receptors specifically suppresses pain hypersensitivity. J Neuroscience: Official J Soc Neurosci 34(15):5322–5334. https://doi.org/10.1523/JNEUROSCI.4703-13.2014

Article  CAS  Google Scholar 

Gonzalez LL, Garrie K, Turner MD (2020) Role of S100 proteins in health and disease. Biochim Biophys Acta Mol Cell Res 1867(6):118677. https://doi.org/10.1016/j.bbamcr.2020.118677

Article  CAS  PubMed  Google Scholar 

Hattori Y, Jojima T, Tomizawa A, Satoh H, Hattori S, Kasai K, Hayashi T (2010) A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells. Diabetologia 53(10). https://doi.org/10.1007/s00125-010-1831-8

Article  PubMed  Google Scholar 

Jiang X, Zhao W, Zhao T, Yang M, Yuan H, Qian J, Xiang Z (2021) S100A4 in spinal substantia gelatinosa from dorsal root ganglia modulates neuropathic pain in a rodent spinal nerve injury model. J Pain Res 14:665–679. https://doi.org/10.2147/JPR.S293462

Article  PubMed  PubMed Central  Google Scholar 

Ma J, Shi M, Zhang X, Liu X, Chen J, Zhang R, Wang X, Zhang H (2018) GLP–1R agonists ameliorate peripheral nerve dysfunction and inflammation via p38 MAPK/NF–kappaB signaling pathways in streptozotocin–induced diabetic rats. Int J Mol Med 41(5):2977–2985. https://doi.org/10.3892/ijmm.2018.3509

Article  CAS  PubMed  Google Scholar 

Mc Dougall JJ, Reid AR (2022) Joint damage and neuropathic pain in rats treated with lysophosphatidic acid. Front Immunol 4:13:811402. https://doi.org/10.3389/fimmu.2022.811402

Article  CAS  Google Scholar 

Meijer C, de Vries EG, Marmiroli P, Tredici G, Frattola L, Cavaletti G (1999) Cisplatin-induced DNA-platination in experimental dorsal root ganglia neuronopathy. Neurotoxicology 20(6):883–887 PMID: 10693969

CAS  PubMed  Google Scholar 

Moetamani-Ahmadi M, Mahmoud Ahmadzadeh A, Alaei M, Zafari N, Negahbanzaferanloo Z, Pourbagher-Shahri AM, Forouzanfar F, Fiuji H, Mahaki H, Khazaei M, Gataa IS, Ferns GA, Peters GJ, Batra J, Lam AK, Giovannetti E, TanzadehPanah H, Avan A (2024) Pegylated nanoliposomal cisplatin ameliorates chemotherapy-induced peripheral neuropathy. Int J Pharm 5:652:123839. https://doi.org/10.1016/j.ijpharm.2024.123839

Article  CAS  Google Scholar 

Moustafa PE, Abdelkader NF, El Awdan SA, El-Shabrawy OA, Zaki HF (2018) Liraglutide ameliorated peripheral neuropathy in diabetic rats: involvement of oxidative stress, inflammation and extracellular matrix remodeling. J Neurochem 146(2):173–185. https://doi.org/10.1111/jnc.14336

Article  CAS  PubMed  Google Scholar 

Paccola CC, Gutierrez VP, Longo I, Juliano L, Juliano MA, Giorgi R (2008) Antinociceptive effect of the C-terminus of murine S100A9 protein on experimental neuropathic pain. Peptides 29(10):1806–1814. https://doi.org/10.1016/j.peptides.2008.05.023

Article  CAS  PubMed  Google Scholar 

Paladugu L, Gharaibeh A, Kolli N, Learman C, Hall TC, Li L, Rossignol J, Maiti P, Dunbar GL (2021) Liraglutide Has Anti-Inflammatory and Anti-Amyloid Properties in Streptozotocin-Induced and 5xFAD Mouse Models of Alzheimer’s Disease. Int J Mol Sci 22(2). https://doi.org/10.3390/ijms22020860

Article  PubMed  PubMed Central  Google Scholar 

Parthsarathy V, Holscher C (2013) Chronic treatment with the GLP1 analogue liraglutide increases cell proliferation and differentiation into neurons in an AD mouse model. PLoS ONE 8(3):e58784. https://doi.org/10.1371/journal.pone.0058784

Article  CAS  PubMed  PubMed Central  Google Scholar 

Patera F, Cudzich-Madry A, Huang Z, Fragiadaki M (2019) Renal expression of JAK2 is high in polycystic kidney disease and its Inhibition reduces cystogenesis. Sci Rep 9(1):4491. https://doi.org/10.1038/s41598-019-41106-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Perry T, Holloway HW, Weerasuriya A, Mouton PR, Duffy K, Mattison JA, Greig NH (2007) Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy. Exp Neurol 203(2):293–301. https://doi.org/10.1016/j.expneurol.2006.09.028

Article  CAS  PubMed  Google Scholar 

Seretny M, Currie GL, Sena ES, Ramnarine S, Grant